New AHA Statement Supports Single-Pill Combo Therapy for Hypertension
The American Heart Association endorses single-pill combination therapy to improve hypertension management and reduce cardiovascular risks among U.S. adults.
The American Heart Association endorses single-pill combination therapy to improve hypertension management and reduce cardiovascular risks among U.S. adults.
CMS issues National Coverage Determination for FDA-approved renal denervation treatment under Coverage with Evidence Development for uncontrolled hypertension in Medicare patients.